RE:RE:Roche's 'Brain Shuttle' and RNA
JD,
I'm wondering if you can comment on this part of the article (I was thinking BTI will get something very similar...and soon):
"Under the terms of the agreement, Roche will make an upfront payment of $30 million to Isis, with total payments related to license fee and pre- and post-licensing milestone payments reaching potentially $362 million, including up to $80 million in potential commercial milestone payments. In addition, Isis will receive tiered royalties on sales of the drugs. Roche has the option to license the drugs from Isis through the completion of the first Phase 1 trial. Prior to option exercise, Isis is responsible for the discovery and development of an antisense drug targeting HTT protein. Roche and Isis will work collaboratively on the discovery of an antisense drug utilizing Roche's "brain shuttle" program. If Roche exercises its option, it will be responsible for global development, regulatory and commercialization activities for all drugs arising out of the collaboration.
BTW - Sir_Holler and Waterlootech: Do you think RH is not doing everything in his power to get a deal done? As JD has said it's in pharmas hands and besides RH has way more to gain then all of us here so I'm quite sure he's just as eager as you and I. In regards to management shuffle, don't be silly - it's solid. We're in good hands.